TDOC.TO
TD Global Healthcare Leaders Index ETF
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 108.9 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Apr 07, 2021 |
| Regulation | |
| Fund Website | link... |
| Distributions | |
| Currency | CAD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| UNITEDHEALTH GROUP INC | 2.6 % |
| JOHNSON & JOHNSON | 2.5 % |
| GILEAD SCIENCES INC | 2.3 % |
| NOVARTIS AG | 2.3 % |
| ELEVANCE HEALTH INC | 2.3 % |
| MERCK & CO. INC. | 2.3 % |
| BRISTOL-MYERS SQUIBB CO | 2.3 % |
| PFIZER INC | 2.3 % |
| GSK PLC | 2.2 % |
| ASTRAZENECA PLC | 2.2 % |
Constituent Breakdown
| Number of holdings | 112 |
| Herfindahl-Hirschman Index | 150 |
| Wgt avg mkt cap (mns) | $132,901 |
| Large cap (>$10bn) | 94.5% |
| Mid cap ($2-10bn) | 2.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 96.5% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 60.1 % |
 |
JAPAN | 8.3 % |
 |
BRITAIN | 5.9 % |
 |
SWITZERLAND | 5.4 % |
 |
GERMANY | 3.0 % |
 |
IRELAND | 2.5 % |
 |
DENMARK | 2.5 % |
 |
FRANCE | 2.1 % |
 |
NETHERLANDS | 1.8 % |
 |
AUSTRALIA | 1.4 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -5.2% | 4.4% | 1.7% | 3.1% | 4.0% | -- | -- | 4.1% |
| Dividend Yield | 0.3% | 1.3% | 1.4% | 2.0% | 1.7% | -- | -- | 1.6% |
| Total Returns | -5.0% | 5.6% | 3.1% | 5.1% | 5.7% | -- | -- | 5.7% | Ann. Volatility | 13.9% | 13.2% | 13.2% | 12.2% | 12.8% | -- | -- | 12.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.46 | 17% |
| MSCI EAFE | 0.48 | 30% |
| MSCI Emg Mkts | 0.22 | 11% |
Liquidity Measures
| Avg. volume (000) | 12 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $18.62 |
| Relative strength (RSI) | 47 |
| MACD/Signal | -0.04/-0.10 |
| Bollinger Bands (Upper/Lower) | $18.78/$18.10 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. TDOC.TO |
Expenses vs. TDOC.TO |
ALTAR Score™ vs. TDOC.TO |
|---|---|---|---|---|
| MHCD.TO | Middlefield Healthcare Dividend ETF | 50.1% | +50 bp | -1.7% |
| ZUH.TO | BMO Equal Weight US Health Care Hedged to CAD Index ETF | 46.2% | 0 bp | -1.5% |
| ZHU.TO | BMO Equal Weight US Health Care Index ETF | 45.5% | 0 bp | -1.8% |
| HIG.TO | Brompton Global Healthcare Income & Growth ETF | 39.3% | +40 bp | -0.2% |
| LMAX.TO | Hamilton Healthcare YIELD MAXIMIZER TM ETF | 37.4% | +30 bp | +0.0% |
| FHH.TO | First Trust AlphaDEX U.S. Health Care Sector Index ETF | 36.3% | +41 bp | +0.6% |
| HHL.TO | Harvest Healthcare Leaders Income ETF | 35.9% | +50 bp | -0.5% |
| MEDX.TO | Global X Equal Weight Global Healthcare Index ETF | 34.1% | +5 bp | +0.5% |
| XEXP.TO | iShares Exponential Technologies Index ETF | 18.7% | +4 bp | -3.0% |
| TULV.TO | TD Q U.S. Low Volatility ETF | 16.9% | -5 bp | -1.4% |
Risk and Returns: TDOC.TO vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (CAD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/18/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.3%
ALTAR SCORE™
87th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 731 funds in the Global Equity category with an average
ALTAR Score™ of 4.3% and a standard deviation
of 2.6%. TDOC.TO's ALTAR Score™ is approximately 1.1 standard
deviations above the category average. This places TDOC.TO in the 87th percentile
among funds in the category.
Sell-Side Consensus
$22.94
PRICE TARGET
+21.2%
UPSIDE